quantisnow
FeedTopReportsPricing
⌘K
Live feed
21:00:10·1186d
INSIDERFiling
Ayala Pharmaceuticals Inc. logo

SEC Form 4: Mamluk Roni returned 265,345 shares to the company, closing all direct ownership in the company

AYLA· Ayala Pharmaceuticals Inc.
Consumer Discretionary
Original source

Companies

  • AYLA
    Ayala Pharmaceuticals Inc.
    Consumer Discretionary

Recent analyst ratings

  • Dec 20UpdateMaxim Group$22.00
  • Dec 20UpdateHC Wainwright & Co.$18.00
  • Nov 30UpdateJefferies$17.00
  • Aug 17UpdateOppenheimer$25.00
  • Jul 13UpdateLadenburg Thalmann$29.00

Related

  • INSIDER904d
    SEC Form 3 filed by new insider Martell Bridget A
  • INSIDER904d
    SEC Form 3 filed by new insider Orbach Pini
  • INSIDER905d
    SEC Form 3 filed by new insider Golan Roy
  • SEC1120d
    SEC Form 10-K filed by Ayala Pharmaceuticals Inc.
  • 13D/G1170d
    SEC Form SC 13G/A filed by Ayala Pharmaceuticals Inc. (Amendment)
  • 13D/G1172d
    SEC Form SC 13G filed by Ayala Pharmaceuticals Inc.
  • 13D/G1172d
    SEC Form SC 13G/A filed by Ayala Pharmaceuticals Inc. (Amendment)
  • SEC1179d
    SEC Form 15-12G filed by Ayala Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022